VAPAWAY.EU - Research and education on VAP prevention
  • Home
  • Articles
  • GuideLines
  • Links
  • About VAPAWAY
  • Training
  • Contacts

Login








Lost Password?

Register to receive updated data on VAPAWAY initiative

Agenda

 

9 - 12 March 2010

ISICEM International Symposium on Intensive Care and Emergency Medicine - Brussels (Belgium)

ISICEM

 

9 -11 June 2010

EACTA European Association of Cardiothoracic Anaesthesiologists - Edinburgh (UK)

EACTA

 

12-15 June 2010

ESA European Society of Anaesthesiology - Helsinki (Finland)

ESA

 

18-22 September 2010

ERS European Respiratory Society - Barcellona (Spain)

ERS

 

9 -13 October 2010

ESICM European Society of Intensive Care Medicine - Barcellona (Spain)

ESICM

  

 

> International events   

> Local events 

test


EFFECT OF VANCOMYCIN PLUS RIFAMPICIN IN THE TREATMENT OF NOSOCOMIAL METHICILLIN RESISTANT STAPHYLOCO PDF Print E-mail
Friday, 26 March 2010

 Jung YJ. et al

About this article:"Methicilin-resistant Staphilococcus aureus  nosocomial pneumonia is a very severe infectious disease with a high mortality . Up to know vancomycin and linezolid are the two main antibiotics  recommended in the guidelines for the treatment of this type of nosocomial pneumonia. In this randomized study  the addition  of rifampicin to vancomycin resulted  in a higher significant clinical cure  when compared to vancomycin alone. However, neither the micobiological eradication nor mortality differed  between  groups.  This study was based on "in vitro data" that suggests that adding rifampicin to vancomycin  increases  the bactericidal activity particularly in foci in wich antibiotics are difficult to reach.Larger studies are warranted"

Read more...
 
ULTRASOUND ASSESMENT OF ANTIBIOTIC-INDUCED PULMONARY REAERATION IN VAP PDF Print E-mail
Friday, 26 March 2010

 Bouhemad B. et al

About this article:"The clinical parameters for the follow-up  evolution of VAP are not well established. Bed-side chest X-ray is not  a very reliable technique in ventilated patients. Using a reparation socore  authors found that lung bed side ultrasonography (reareation of more than 400 mL in the CT Scann)  was associated with successful antimicrobial therapy. We do not know now how useful can be in the future the application  of bed-side ultrasonography. However, and without no doubt , this technique opens new insights for the better assessment of VAP treatment response"

Read more...
 
NON-ADHERENCE TO GUIDELINES:AN AVOIDABLE CAUSE OF FAILURE OF EMPIRICAL ANTIMICROBIAL THERAPY IN THE PDF Print E-mail
Friday, 26 March 2010

Garcin F. et al 

About this article:"There is little evidence   about the influence on outcome  of adherence of guidelines  in the treatment of VAP. In this observational study authors  report  87% initial adequate antibiotic treatment in a series of VAP patients. In fifty cases difficult to treat bacteria were isolated. The risk factors          included prior antimicrobial treatment, late -onset pneumonia, and health-care associated pneumonia. These cases represented the 23% of late-onset cases  and were the main cause of initial inadequacy antibiotic therapy."

Read more...
 
A COMPARISON OF LINEZOLID WITH GLYCOPEPTIDES IN SEVERE MRSA PNEUMONIA PDF Print E-mail
Monday, 01 February 2010

Abunasser J. et al

About this article:"This review article  covers the controversy of Linezolid vs glycopeptides for the treatment of severe MRSA pneumonia.  Although clinical studies are inconclusive., animal studies in a model of mecahnically ventilated piglet shows differences in favor of  Linezolid compared to vancomycin and teicoplanin. These differences were attributed to  other factors than direct antimicrobial  properties."

Read more...
 
NEBULIZED CEFTAZIDIME IN EXPERIMENTAL PNEUMONIA CAUSED BY PARTIALLY RESISTANT PSEUDOMONAS AERUGINOSA PDF Print E-mail
Monday, 01 February 2010

 Ferrari F. et al

About this article:"In this piglet mechanically ventilated animal model  of Pseudomonas aeruginosa, partially resistant  VAP , nebulized or systemic ceftazidime (MIC: 16 mg/L) were administered. Very interestingly, nebulized ceftazidime was more effective in killing Pseudomonas aeruginosa in lungs. This animal study support the concept of administering nebulized antibiotics in multidrug resistant microorganism VAP."

Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 Next > End >>

Results 1 - 9 of 67
Select and watch
from the following webinars

 


Join us on www.smartonweb.org

Partner

VAPAWAY is proudly supported by Covidien.

http://www.covidien.com